New Treatments for Recurrent Implantation Failure with guest Dr. Jenna Turocy

Recurrent implantation failure isn't a personal shortcoming—it's a medical condition, and the most promising new treatments are reshaping how we approach it. Dr. Jenna Turocy, a fertility specialist and biomedical engineer turned reproductive scientist, reveals that cutting-edge therapies like intrauterine platelet-rich plasma (PRP), peripheral blood mononuclear cell infusions, and subcutaneous granulocyte colony-stimulating factor (GCSF) are showing real promise in improving implantation rates—especially for patients with thin endometrial linings or a history of multiple failed transfers. But she also delivers a sobering warning: gene-editing tools like CRISPR, while scientifically fascinating, remain dangerously unready for clinical use, with one-third of embryos losing entire chromosomes during experimental editing. Her research underscores a critical truth: innovation must be tempered by caution. Patients, she insists, should advocate for themselves—not for experimental gene fixes, but for evidence-backed treatments like PRP and immune modulation, and to seek out specialists who stay current on the latest science. This episode is a call to action: stop blaming yourself, start demanding better care. The conversation shifts from lab bench to bedside with practical, patient-centered strategies. PRP, drawn from a patient’s own blood and injected into the uterus, acts like a regenerative 'growth cocktail' that thickens the uterine lining.